Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FAHF-2 (Food Allergy Herbal Formula-2) is a Chinese herbal medicine formula developed for treating food allergies. It consists of 9 herbs derived from the classical Traditional Chinese Medicine formula Wu Mei Wan, which dates back approximately 2,000 years. The formula has shown promising results in both animal studies and human clinical trials. FAHF-2 is a 9-herb formula based on Traditional Chinese Medicine that has demonstrated the ability to block peanut anaphylaxis in murine models. It has undergone several phases of clinical trials to evaluate its safety, tolerability, and efficacy for treating food allergies. The formula works through multiple immunomodulatory mechanisms, including suppression of inflammatory cytokines (TNF-α, IFN-γ, IL-17, IL-6), reduction of IL-5 levels, and inhibition of basophil activation. In clinical trials, FAHF-2 has been found to be safe and well-tolerated, though the high pill burden (36 pills daily) led to compliance issues. This prompted the development of more concentrated versions: B-FAHF-2 (butanol purified) and E-B-FAHF-2 (ethyl acetate butanol purified), which reduced the required dosage to 10 pills daily. The formula has received FDA investigational new drug approval for clinical trials in both food allergies and Crohn's disease. Studies have shown that FAHF-2 and its purified derivatives have immunomodulatory effects that may benefit patients with multiple food allergies and inflammatory bowel conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FAHF-2.